A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Trial Identifier:	D5671C00009
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Ltd
NCTID::	NCT05294458
Start Date:	March 2022
Primary Completion Date:	September 2022
Study Completion Date:	September 2022
Condition:	Chronic Kidney Diseases; Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.